Medtronic is introducing in the United States its deep brain stimulation therapy (DBS) as an option for treating drug-resistant epilepsy.
About a third of epilepsy patients don’t respond positively to existing drug regimens, leaving patients with little recourse against the disease. DBS therapy involves delivering small pulses of electric (Read more...)